Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
AstraZeneca
Dow
Johnson and Johnson
Medtronic

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ubiquinol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Ubiquinol?

Ubiquinol is an investigational drug.

There have been 11 clinical trials for Ubiquinol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2017.

The most common disease conditions in clinical trials are Heart Failure, Mitochondrial Diseases, and Fatigue. The leading clinical trial sponsors are Beth Israel Deaconess Medical Center, Kaneka Pharma America LLC, and Children's Hospital Medical Center, Cincinnati.

There are one hundred and three US patents protecting this investigational drug and six hundred and forty-nine international patents.

Recent Clinical Trials for Ubiquinol
TitleSponsorPhase
Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical TrialCairo UniversityPhase 1
CoQ10 and D-ribose in Patients With Diastolic Heart FailureUniversity of Kansas Medical CenterPhase 2
Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic InfertilityPharmEvo Pvt LtdPhase 4

See all Ubiquinol clinical trials

Clinical Trial Summary for Ubiquinol

Top disease conditions for Ubiquinol
Top clinical trial sponsors for Ubiquinol

See all Ubiquinol clinical trials

US Patents for Ubiquinol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ubiquinol   Start Trial Pre-spray emulsions and powders containing non-polar compounds Virun, Inc. (Pomona, CA)   Start Trial
Ubiquinol   Start Trial Nutrient combinations for affecting an aging process BioMarker Pharmaceuticals, Inc. (San Jose, CA)   Start Trial
Ubiquinol   Start Trial Nutritional supplement compositions containing C60-fullerene-phytonutrient-triglyceride complexes for sub-cellular phytonutrient delivery NextGen Research (Greenville, SC)   Start Trial
Ubiquinol   Start Trial Oxidation resistant bioprosthetic tissues and preparation thereof The Children's Hospital of Philadelphia (Philadelphia, PA)   Start Trial
Ubiquinol   Start Trial Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Veiled Therapeutics LLC (Etta, MS)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ubiquinol

Drugname Country Document Number Estimated Expiration Related US Patent
Ubiquinol Canada 2961829 2034-09-18   Start Trial
Ubiquinol European Patent Office 3193834 2034-09-18   Start Trial
Ubiquinol World Intellectual Property Organization (WIPO) 2016044805 2034-09-18   Start Trial
Ubiquinol World Intellectual Property Organization (WIPO) 2016044813 2034-09-18   Start Trial
Ubiquinol European Patent Office 3057603 2033-10-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Boehringer Ingelheim
Medtronic
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.